The Dharmacon website will be undergoing scheduled maintenance starting Monday, November 19th at 9:00 a.m. (MST) and continuing until Tuesday, November 20th until 6:00 p.m. (MST). During this time period, there may be intermittent outages of the website. We thank you for your patience as we complete this necessary maintenance. If you need assistance, please reach out to our
customer support team
Home | Resources | FAQs
Why do I need to use a Non-targeting control shRNA with my SMARTchoice Inducible shMIMIC microRNA?
It's a good idea to use a non-targeting control even if there is little of no shMIMIC microRNA expression in the absence of doxycyxline. Although doxycycline is generally accepted as “inert,” some cellular phenotypes, such as reduced growth rate, may
be observed upon exposure to doxycycline. In addition, fluorescent reporters such as TurboGFP and TurboRFP can
cause some subtle changes in cellular phenotypes. To rigorously control for both of these effects, it is necessary to
use a vector-matched Non-Targeting Control shRNA to identify true mature microRNA-dependent phenotypes.